Antimicrobial Resistance inHaemophilus influenzae:How Can We Prevent the Inevitable? Commentary on Antimicrobial Resistance inH. influenzaeBased on Data from the TARGETed Surveillance Program
Open Access
- 15 August 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (s4) , S234-S238
- https://doi.org/10.1086/430783
Abstract
Haemophilus influenzae is an important cause of respiratory tract infections, particularly in elderly persons. It is the major bacterial pathogen in acute exacerbations of chronic bronchitis (AECB) and also causes otitis media and sinusitis. In many cases, treatment is empiric, and there is a lack of understanding of resistance issues with this bacterium. There is little understanding of the epidemiology of H. influenzae respiratory infections, although some strains may be replaced by new strains that cause more severe infections. There is almost no information on how these bacteria may spread in the community. Ampicillin resistance is significant (it may be >30%), and there are few oral agents capable of reducing organism burden. There is little understanding of the epidemiology of H. influenzae respiratory infections, and almost no information on how these bacteria may spread in the community. Recent evidence suggests that these bacteria may behave in a similar way to Streptococcus pneumoniae. If that proves correct, then it will be important to follow these organisms in the community to determine if resistance determinants may spread more widely than we have thus far believed. The implications for treatment, infection prevention and control, and public health should not be underestimated as it has been with other organisms such as S. pneumoniae and Staphylococcus aureus.Keywords
This publication has 15 references indexed in Scilit:
- Rapidly Increasing Prevalence of β-Lactamase-Nonproducing, Ampicillin-Resistant Haemophilus influenzae Type b in Patients with MeningitisAntimicrobial Agents and Chemotherapy, 2004
- Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000International Journal of Antimicrobial Agents, 2004
- Dynamics of Long-Term Colonization of Respiratory Tract byHaemophilus influenzaein Cystic Fibrosis Patients Shows a Marked Increase in Hypermutable StrainsJournal of Clinical Microbiology, 2004
- Laboratory Detection of Haemophilus influenzae with Decreased Susceptibility to Nalidixic Acid, Ciprofloxacin, Levofloxacin, and Moxifloxacin Due to gyrA and parC MutationsJournal of Clinical Microbiology, 2004
- Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countriesInternational Journal of Antimicrobial Agents, 2004
- PROTEKT 1999–2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South KoreaInternational Journal of Antimicrobial Agents, 2004
- Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance ProgrammeJournal of Antimicrobial Chemotherapy, 2003
- The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agentsJournal of Antimicrobial Chemotherapy, 2003
- Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine eraPublished by American Medical Association (AMA) ,1993
- Antibacterial Therapy for Lower Respiratory Tract Infections in Adults: A ReviewClinical Infectious Diseases, 1992